CROSSJECT optimizes its production with the ZENEO® Nest

Pharmaceutical company CROSSJECT announces a new production module, the ZENEO® Nest, to enhance the filling capacity of its ZENEO® Factory. This development aims to facilitate the aseptic filling of glass medication containers, essential for the brand's needle-free auto-injectors. Implementation of this innovation is planned for December 2025.

This module will enable increased production volumes thanks to rapid container pre-assembly. Compatible with various equipment, it offers flexibility and speed to CROSSJECT's CDMO partners. The first ZENEO® Nest has been successfully tested with EUROFINS.

CROSSJECT secured financing from LCL for this project, as part of its financial diversification strategy. This step supports the deployment of products such as ZEPIZURE® and other solutions targeting medical emergencies.